PatentPatent Analysis

EP3626270

NOVARTIS
Application Number
EP19202854A
Filing Date
Aug 26, 2014
Status
Granted And Under Opposition
Sep 8, 2023
Grant Date
Oct 11, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3626270B1 was granted to Novartis on Oct 11, 2023 following the initial filing on Aug 26, 2014 under the application number EP19202854A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ELPEN PHARMACEUTICALJul 11, 2024ADMISSIBLE
GENERICS UKJul 11, 2024ADMISSIBLE
LANYON OPPOSITIONSJul 11, 2024ADMISSIBLE
ZENTIVA KSJul 11, 2024ADMISSIBLE
BULLE DRJul 10, 2024ADMISSIBLE
CAMULONJul 10, 2024ADMISSIBLE
DR SCHONJul 10, 2024ADMISSIBLE
POLPHARMAJul 10, 2024ADMISSIBLE
SYNTHONJul 10, 2024ADMISSIBLE
TEVA PHARMACEUTICALSJul 10, 2024ADMISSIBLE
WUESTHOFF & WUESTHOFFJul 10, 2024ADMISSIBLE
HOFFMANN EITLEJul 9, 2024ADMISSIBLE
EGISJul 8, 2024ADMISSIBLE
HAMM & WITTKOPPJul 5, 2024ADMISSIBLE
BETAPHARM ARZNEIMITTELJul 2, 2024ADMISSIBLE
ALFRED E TIEFENBACHERJun 25, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents